Cargando…
Current Insights into the Management of Late Chemotherapy Toxicities in Pediatric Osteosarcoma Patients
With ever increasing long-term, disease free survival rates, long-term toxicities of otherwise successful therapy have gained increasing importance. They can be grouped into potentially life-threatening, especially secondary malignancies and anthracycline cardiomyopathies, potentially disabling, par...
Autores principales: | Hecker-Nolting, Stefanie, Langer, Thorsten, Blattmann, Claudia, Kager, Leo, Bielack, Stefan S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647031/ https://www.ncbi.nlm.nih.gov/pubmed/34880679 http://dx.doi.org/10.2147/CMAR.S287908 |
Ejemplares similares
-
Advances in the management of osteosarcoma
por: Bielack, Stefan S., et al.
Publicado: (2016) -
Establishment, Maintenance, and Performance of the Cooperative Osteosarcoma Study Group (COSS)
por: Bielack, Stefan S., et al.
Publicado: (2023) -
Solitary pulmonary metastases at first recurrence of osteosarcoma: Presentation, treatment, and survival of 219 patients of the Cooperative Osteosarcoma Study Group
por: Mettmann, Vanessa L., et al.
Publicado: (2023) -
Review of mifamurtide in the treatment of patients with osteosarcoma
por: Kager, Leo, et al.
Publicado: (2010) -
High-Grade Osteosarcoma of the Foot: Presentation, Treatment, Prognostic Factors, and Outcome of 23 Cooperative Osteosarcoma Study Group COSS Patients
por: Schuster, Anne J., et al.
Publicado: (2018)